MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » SuperSonic Imagine CEO Egelund out after 8 months | Personnel Moves

SuperSonic Imagine CEO Egelund out after 8 months | Personnel Moves

By

MassDevice.com Personnel Moves

SuperSonic Imagine said today its CEO Tom Egelund, only appointed as chief in April, will be replaced by supervisory board member Bernard Doorenbos who will operate as interim president and CEO.

Doorenbos has held positions at Philips, Thomson CSF, Signaal USFA and acted as CEO of molds and plastic component company Axxicon Group NV, Neways Electronics International and Vilenzo International. He has been a member on SuperSonic Imagine’s supervisory board since May.

Egelund in April succeeded founder Jacques Souquet, who transitioned to CIO to concentrate on overseeing other aspects of SuperSonic Imagine, the company said.

Before moving to SuperSonic Imagine, Egelund spent 10 years at printing and copying hardware company Oce as exec veep, and held senior exec positions at Royal Philips (NYSE:PHG). SuperSonic Imagine did not comment on the terms or conditions of the personnel transition.

“It is a pleasure to welcome Bernard as president and chief executive officer. His main objectives will be to strengthen the commercial action in the company’s key territories, increase its visibility within the investment community, and continue to develop the company through its pipeline of products and partnerships. Bernard’s expertise in managing technological and industrial companies at this stage of development will be extremely helpful to the team. I am confident in his ability to implement the company’s strategy,” supervisory board chair Hermann Requardt said in prepared remarks.

 NuVasive taps Ex-GE Hanson as GC, exec veep of strategy & corp dev
NuVasive Inc. (NSDQ:NUVA) said earlier this month it tagged ex-GE Healthcare (NYSE:GE) corporate veep and senior exec Jason Hanson as new general counsel and exec veep of strategy and corporate development. Hanson will assume responsibilities as GC from Jason Hannon, who moved to exec veep of international in July.
Read more

 Lantheus lifts Crowley to CFO, replacing Bakewell
Lantheus said this week it lifted current chief accounting officer Jack Crowley to interim CFO, replacing CFO John Bakewell who is resigning to accept another position elsewhere. Crowley has been with Lantheus since 2010.
Read more

 StimGuard ’s new prez is ex-CVRx’s Moore
StimGuard said earlier this month it named ex-CVRx veep of sales operations and market development Tom Moore as its new president, effective immediately
Read more

 RAPS vet exec director Keramidas retires
The Regulatory Affairs Professionals Society said last week its 20-year vet exec director Sherry Keramidas will retire from her position as of January 31, 2016.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Keep the end in mind when choosing a medtech partner
    There are five general categories of medtech vendor partners. If the end is apparent in the beginning, the correct type of partner will be more apparent. Jim Reed, Minnetronix Medical Stephen Covey gave the business world this mantra in one of his bestsellers: “Start with the end in mind.” Whether they didn’t read the book… […]
  • Orthofix launches Fiberfuse Strip bone graft
    Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S. Lewisville, Texas–based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures. FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with… […]
  • Thermo Fisher Scientific beats The Street in Q2 results
    Thermo Fisher Scientific (NYSE:TMO) today posted second-quarter results that beat the overall consensus on Wall Street. The Waltham, Mass.–based company reported profits of $1.8 billion, or $4.61 per share, on sales of $9.3 billion for the three months ended July 1, 2021, for a bottom-line gain of 58.1% on sales growth of 34.1% compared with… […]
  • Choosing the Right Rubber Material and Process for Your Medical Parts
    When it’s time to design and develop a new medical device that calls for an elastomer component, there are a number of material options and manufacturing processes to consider. The long list of material properties impacting performance includes your prospective polymer’s end-use environment, chemical compatibility, hardness, compression set, tensile properties and manufacturability — to name… […]
  • 3M’s healthcare segment registers growth in Street-beating Q2
    3M (NYSE:MMM) reported second-quarter results that beat the consensus forecast — with the company’s healthcare segment showing especially robust growth. The St. Paul, Minn.–based company posted profits of $1.5 billion, or $2.59 per share, on sales of $9 billion for the three months ended June 30, 2021, for a 16.7% bottom-line gain on sales growth of… […]
  • Evren Technologies earbud PTSD treatment device nabs FDA breakthrough device designation
    Evren Technologies this week announced that it received FDA breakthrough device designation for its Phoenix earbud device that treats PTSD. Gainesville, Fla.-based Evren Technologies designed the Phoenix device as a discreet earbud design that delivers transcutaneous auricular vagal nerve stimulation in a closed-loop system. It can be paired with the company’s PTSD symptom tracking app… […]
  • BD acquires resorbable polymer maker Tepha
    BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed amount. Franklin Lakes, N.J.–based BD said that it will use Lexington, Mass.–based Tepha’s resorbable polymer technology to accelerate growth of the company’s surgical mesh for soft tissue repair, reconstruction and regeneration. Tepha’s GalaFlex portfolio is also included in the acquisition.… […]
  • LifeSignals remote patient monitor wins FDA clearance
    LifeSignals today announced that it has received FDA 510(k) clearance for its LX1550 multi-parameter remote monitoring platform. Fremont, Calif.–based LifeSignals designed the LX1550 to continuously collect patient physiological data from home and in healthcare settings. The platform has a single-use wearable multi-parameter biosensor that records electrocardiography (ECG), heart rate, respiration rate, skin temperature and body… […]
  • Blackrock Neurotech and ClearPoint Neuro want to automate brain implant surgeries
    ClearPoint Neuro (NSDQ:CLPT) announced an agreement with Blackrock Neurotech to develop automated technologies for brain implant surgeries. The partnership will seek to develop an automated surgical solution for implanting brain-computer interfaces (BCIs) into patients with neurological disorders — including from paralysis, ALS, blindness and hearing loss. Solana Beach, Calif.–based ClearPoint Neuro said in a news… […]
  • New Mountain Capital to acquire Flexan
    New Mountain Capital’s ILC Dover today announced that it has reached a definitive agreement to acquire Flexan for an undisclosed amount. Lincolnshire, Ill.–based Flexan is a contract design and manufacturing company specializing in high-precision silicone, rubber and thermoplastic components for the medical device industry. The acquisition will allow both companies to serve a broader client… […]
  • How COVID-19 changed medical device clinical trials forever
    The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on… […]